Youjia Health Secures Tens of Millions in Series B Funding to Advance Digital Commercial Insurance-Integrated Healthcare Platform

On February 8, VCBeat learned that Health care technology(Beijing)Technology Co., Ltd. (hereinafter referred to as “Youjia Health”) announcedCompleted the first tranche of its Series B financing, amounting to tens of millions of RMB.This round of financing was exclusively completed by HWealth Capital. The funds raised will be used to continuously build the “Family Doctor and Premium Care Core” medical service system of Youjia Health, develop a user-centric curated medical service network, further strengthen the layout of the pharmaceutical and medical device network, enhance the construction of a data-driven platform for innovative healthcare products, and improve professional health insurance risk control and medical service management capabilities.

Founded in June 2017, UJIA Health has gradually developed core competencies in medical and nursing services alongside the rapid growth of commercial health insurance. By leveraging a curated medical network, it connects healthcare providers, insurers, and customers, offering product innovation, risk control, and healthcare management services to insurance institutions and their clients.

As of the end of 2021, Youjia Health had established a closed-loop service and product ecosystem encompassing “medical care, health management, pharmaceuticals, and insurance.” Youjia Health’s proprietary commercial insurance medical network has built a team of over 20,000 commercial insurance-affiliated physicians and more than 30,000 commercial insurance-affiliated nurses, with direct billing/advance payment service coverage across more than 10,000 public hospitals. Its online-to-offline managed healthcare service system, “Family Doctor Premium Care,” has gained recognition from numerous large insurance companies.

Meanwhile, Youjia Health adheres to the “user-centric” service philosophy and continuously expands its curated digital healthcare network. It has now established a medical service platform directly connected to over 30,000 offline pharmacies, more than 2,000 physical examination centers, over 2,000 dental clinics, and more than 1,500 ophthalmology centers. In November 2021, Youjia Health formed a joint venture with Qingzhan Technology, an affiliate of the Institute for Artificial Intelligence at Tsinghua University, to co-establish the AI Commercial Insurance Innovation Laboratory and explore pathways for transitioning from digitalization to intelligentization. As capabilities in underlying healthcare networks, innovative services, and data intelligence continue to improve,Youjia Health has established a comprehensive and distinctive online-to-offline managed healthcare service network, emerging as an industry-leading third-party provider amid the broader trend of empowering commercial insurance through the “insurance + services” model.

It is reported that Youjia Health currently has nearly 20 million paying users and has served over 100,000 individuals. The company has established in-depth collaborations with more than 100 insurance companies and internet platforms in areas such as health insurance product innovation, customized customer service, marketing efficiency enhancement, and BBC mall operations. It holds a leading position in niche markets for mid-tier health insurance, represented by million-yuan medical insurance, particularly in direct payment and advance payment services, medical accompaniment and care, and medical appointment arrangements. Current partner institutions include PICC, Ping An, Taikang, ZhongAn, WeSure, Ant Insurance, Datong, Fanhua, and Mingya.

Since May 2021, Youjia Health has successively collaborated with leading insurers such as Taikang Online Insurance, Ping An Property & Casualty Insurance, and PICC Property & Casualty Insurance; leading internet insurance platform WeSure; and leading insurance brokerage firm Datong to jointly develop “Internet Outpatient Insurance.” As an additional benefit attached to million-yuan medical insurance upgrade products, Youjia Health integrates online and offline managed healthcare services.

"Internet Outpatient Insurance" uses "family doctors" as the entry point to provide a one-stop online service for minor illnesses, covering the entire process of online consultation, e-prescribing, real-time claims adjudication, and O2O home delivery of medications. By integrating these with the offline benefits of million-yuan medical insurance—such as in-person medical visits, accompanied consultations, hospitalization advance/direct payment, and post-discharge care—U-Jia Health leverages its core "Family Doctor Premium Care" service capabilities to offer insurers comprehensive healthcare solutions. These solutions encompass product development, medical services, risk control, direct medical payments, and data analytics, thereby helping to construct a user-centric, multi-layered, and multi-dimensional healthcare security system.

In recent years, driven by factors such as population aging, increasing pressure on medical insurance payments, and heightened awareness of health risks in the wake of the COVID-19 pandemic, health insurance has experienced more rapid growth compared to life and property insurance. Consequently, health insurance has become a key focus for insurers, with many actively entering this market segment.

According to Wang Yanping, Founder and CEO of Youjia Health, the core competencies of health insurance lie in product and service innovation capabilities built upon a medical healthcare service system, risk control and pricing management capabilities, as well as data and payment capabilities. While a few insurance companies may consider building a closed-loop “medical care + insurance” ecosystem, most insurers need to achieve such an ecosystem through collaboration with professional third-party partners.

“The high potential and rapid growth of the health insurance market have attracted more insurers to enter this sector. UJia Health aims to become the most professional and reliable partner for insurance companies,” said Wang Yanping. Following the new round of financing, UJia Health will continue to deepen its engagement with the medical service system and provide insurers with customized healthcare solutions, product innovation, and risk management services. This will help insurers continuously offer health insurance products tailored to specific diseases, populations, regions, and scenarios for the middle-class segment within their existing product portfolios.Implement a one-customer, one-family health record with a one-stop service loop. Truly build a user-centric closed-loop ecosystem for health insurance.

“Empowering the intelligent and digital S2B2C platform is another key focus and direction for Youjia Health in delivering value to industry clients,” stated Ding Haochuan, Co-founder and Chairman of Youjia Health. He further explained, “Multi-dimensional service capabilities, along with massive databases on the demand and supply sides—including knowledge bases, tag libraries, and dynamic correlations—can truly unlock intelligent customization for B-end clients and intelligent recommendations for C-end consumers only through a comprehensive big data processing architecture and algorithm engines powered by deep learning. Youjia Health will continue to invest in and develop data intelligence to drive innovation in insurance products and services, in collaboration with its specialized AI innovation laboratory, ‘Youzhan Technology.’”"As the business volume and data scale of Youjia Health continue to expand, the competitive advantages and commercial value driven by data intelligence will become increasingly significant."

As the exclusive investor in this round, Wang Hongwei, Founding Partner of HWealth Capital, stated: "Optimization on the payment side represents the most significant systemic and structural evolution facing China's healthcare industry. Demand-side, supply-side, and policy-driven factors are fueling the robust growth of China's health insurance sector and its derivative managed care services. From the perspective of industrial chain functions and division of labor, health insurance-related businesses require effective support from third-party value-based healthcare service providers, thereby giving rise to rich, diverse, and professional series of medical solution packages. Platforms capable of effectively linking healthcare providers, insurers, and end-users, while possessing strong network effects and comprehensive operational capabilities, have become the essential foundation for competitive participation in the industry. UPlus Health already possesses such competitive strength. In our second strategically significant investment in UPlus Health, we have witnessed over a 40-fold increase in its scaled revenue within less than three years. Through lean strategy, efficient operations, and rapid iteration, the UPlus team has successfully established a fundamental commercial loop connecting healthcare and insurance, entering a phase of rapid upgrading toward higher-dimensional platform value."and became the first profitable third-party value-based healthcare service provider in China’s internet medical and health insurance sector!

Based on the above assessment, Wang Hongwei expressed optimism about the mid-to-long-term value of UPlus Health’s team and business model in empowering health insurance ecosystem products and services, as well as its value in enabling managed care for individual full-lifecycle management through data-driven approaches. Furthermore, the global and China-leading diagnostic and therapeutic technologies invested in by HWealth Capital will synergize with UPlus Health’s long-term development.

HWealth Capital was jointly established by high-performing senior healthcare investors, shareholders of large listed pharmaceutical companies, and leading industrial players in specialized healthcare sectors that are globally advanced and dominant in China. The firm is committed to building an “industry research-, scientific research-, and operations-driven industrial healthcare fund.” Its core team members come from leading domestic and international healthcare industry institutions and research institutes. The team has previously invested in and incubated numerous market and technology leaders in specialized sectors both in China and abroad, including PINS Medical, Hehu Technology, Youjia Health, Ascentage Pharma (6855.HK), Shenzhen Kangtai Biological Products (300601.SZ), Meinian Onehealth Healthcare Holdings (002044.SZ), Kangzhong Medical (688607.SH), Nikkiso (6376.JP), CareConnex, Houkai Medical, Langrun Medical, and Hisky Medical Technology. HWealth Capital focuses on the diagnosis and treatment of major diseases in neurology, oncology, autoimmune disorders, and other therapeutic areas, with a particular emphasis on investing in best-in-class or original diagnostic and therapeutic products that address substantial potential market sizes and are supported by rigorous mechanistic and data-driven evidence.

Kangyu Capital invested in Youjia Health through Kangyu Yiqi (Zibo). As a key hub for the medical and healthcare industry, Zhangdian District of Zibo City serves as the government cornerstone investor in Kangyu Yiqi (Zibo). Leveraging the district committee’s “2+4” industrial strategy, it will collaborate with leading healthcare industry funds to further strengthen the local innovation cluster in the medical and healthcare sector, with a commitment to incubating and cultivating market leaders in specialized segments.